LISDEXAMFETAMINE DIMESYLATE AS TREATMENT FOR ADHD IN CHILDREN PREVIOUSLY TREATED WITH OSMOTIC-RELEASE ORAL SYSTEM METHYLPHENIDATE: PARENTAL IMPRESSIONS

被引：0
|
作者：
Antonucci, D.
Manos, M. [1 ]
Kerney, D. [2 ]
Lopez, F. [3 ]
机构：
[1] Rainbow Babies & Childrens Hosp, Cleveland Clin, Cleveland, OH 44106 USA
[2] InfoMedics Inc, Reading, MA USA
[3] Childrens Dev Ctr, Winter Pk, FL USA
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder
    Zheng, Yi
    Liang, Jian-Min
    Gao, Hong-Yun
    Yang, Zhi-Wei
    Jia, Fu-Jun
    Liang, Yue-Zhu
    Fang, Fang
    Li, Rong
    Xie, Sheng-Nan
    Zhuo, Jian-Min
    CHINESE MEDICAL JOURNAL, 2015, 128 (22) : 2988 - 2997
  • [32] Randomized, 6-Week, Placebo-Controlled Study of Treatment for Adult Attention-Deficit/Hyperactivity Disorder: Individualized Dosing of Osmotic-Release Oral System (OROS) Methylphenidate With a Goal of Symptom Remission
    Goodman, David W.
    Starr, H. Lynn
    Ma, Yi-Wen
    Rostain, Anthony L.
    Ascher, Steve
    Armstrong, Robert B.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (01) : 105 - 114
  • [33] Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder
    Hwang, Jun-Won
    Kim, Bongseog
    Kim, Yeni
    Kim, Tae-Ho
    Seo, Wan-Seok
    Shin, Dong-Won
    Woo, Young-Jae
    Yoo, Heejeong
    Lee, Jeong-Seop
    Lee, Jong-Hun
    Lim, Myung-Ho
    Chung, Young-Chul
    Jung, Chul-Ho
    Yoo, Hanik K.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (06) : 600 - 607
  • [34] Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
    Youran Xu
    Hsingwen Chung
    Meng Shu
    Yanfang Liu
    Yongjing Zhang
    Hong Qiu
    BMC Pediatrics, 23
  • [35] Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
    Xu, Youran
    Chung, Hsingwen
    Shu, Meng
    Liu, Yanfang
    Zhang, Yongjing
    Qiu, Hong
    BMC PEDIATRICS, 2023, 23 (01)
  • [36] Randomised controlled trial of the short-term effects of osmotic-release oral system methylphenidate on symptoms and behavioural outcomes in young male prisoners with attention deficit hyperactivity disorder (ADHD): CIAO-II study: commentary, Asherson et al
    Asherson, Philip
    Forrester, Andrew
    Johansson, Lena
    Thomson, Lindsay
    BRITISH JOURNAL OF PSYCHIATRY, 2024, 225 (03) : 412 - 413
  • [37] Double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder
    Reimherr, Frederick W.
    Williams, Erika D.
    Strong, Robert E.
    Mestas, Ruth
    Soni, Poonam
    Marchant, Barrie K.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (01) : 93 - 101
  • [38] Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study
    Song, Dong-Ho
    Choi, Soul
    Joung, Yoo Sook
    Ha, Eun Hye
    Kim, Boong-Nyun
    Shin, Yee-Jin
    Shin, Dongwon
    Yoo, Hee Jeong
    Cheon, Keun-Ah
    PSYCHIATRY INVESTIGATION, 2012, 9 (03) : 257 - 262
  • [39] The Relationship Between Symptomatic and Functional Changes of Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Treated With Osmotic-Controlled Release Oral Delivery System-Methylphenidate
    Kim, Eunjoo
    Cheon, Keun-Ah
    Joung, Yoo Sook
    Kim, Joo-Young
    Song, Dong-Ho
    CLINICAL NEUROPHARMACOLOGY, 2015, 38 (01) : 30 - 35
  • [40] Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in ADHD: A randomized controlled trial
    Tas Torun, Yasemin
    Isik Taner, Yasemen
    Guney, Esra
    Iseri, Elvan
    APPLIED NEUROPSYCHOLOGY-CHILD, 2022, 11 (04) : 567 - 578
12345